insights_auto
Prečo akcie KVUE stúpli 3,66%?
Preskúmať podrobnejšiechevron_right
KVUE:NYSE
Kenvue Inc
18,67 USD
arrow_upward
+3,66%(+0,66) 1 d.
18,71 USD
arrow_upward
+0,23% (+0,043)bedtimePo uzavretí
Zavreté: 15. 10., 16:00:04 GMT-4 · USD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre KVUE…
Otvoriť
18,38 USD
Vysoká
18,77 USD
Nízka
18,38 USD
Trh. kap.
35,86 mld.
Priem. obj.
24,40 mil.
Objem
26,39 mil.
Dividenda
4,50 %
Štvrťročná dividenda
0,21 USD
Prvý obchodný deň po vyplatení dividendy
21. 9. 2026
Pomer cena/zárobky
21,65
Max. za 52 týž.
20,13 USD
Min. za 52 týž.
14,02 USD
Výnosy na akciu
0,86 USD
Beta
0,48
Akcie v obehu
1,92 mld.
Počet zamestnancov
22 tis.
Otvoriť
18,38 USD
Vysoká
18,77 USD
Nízka
18,38 USD
Trh. kap.
35,86 mld.
Priem. obj.
24,40 mil.
Objem
26,39 mil.
Dividenda
4,50 %
Štvrťročná dividenda
0,21 USD
Prvý obchodný deň po vyplatení dividendy
21. 9. 2026
Pomer cena/zárobky
21,65
Max. za 52 týž.
20,13 USD
Min. za 52 týž.
14,02 USD
Výnosy na akciu
0,86 USD
Beta
0,48
Akcie v obehu
1,92 mld.
Počet zamestnancov
22 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
News Corp
·
pred 3 hodinami
Kenvue Inc. stock rises Thursday, outperforms market
ad-hoc-news.de
·
pred 6 hodinami
Citi keeps USD 19.00 target for Kenvue stock
Yahoo Finance
·
pred 8 hodinami
What to Expect From Kenvue's Next Quarterly Earnings Report
Benzinga
·
pred 8 hodinami
Huggies Maker Kimberly-Clark Sticks To 2026 Profit Outlook
Profil
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index.
CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Wikipedia
Informácie o subjekte Kenvue Inc
Generálny riaditeľKirk Perry
Zamestnanci21,9 tis.
Dátum založenia2022
Hlavné sídloSummit, New Jersey, Spojené štáty americké
OdvetviePersonal care products
Webkenvue.com